Sini Brook Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-01-2025
- Paid Up Capital ₹ 0.10 M
as on 02-01-2025
- Company Age 2 Year, 10 Months
About Sini Brook Biotech
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Maheshkumar Patel, Nisarg Patel, Siddharth Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24200GJ2022PTC129491
- Company No.
129491
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sini Brook Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nisarg Patel  | Director | 18-Feb-2022 | Current |
| Maheshkumar Patel | Director | 18-Feb-2022 | Current |
| Siddharth Patel | Director | 18-Feb-2022 | Current |
| Yashvant Patel | Director | 18-Feb-2022 | Current |
Financial Performance of Sini Brook Biotech.
Enhance accessibility to Sini Brook Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sini Brook Biotech?
Unlock access to Sini Brook Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sini Pharma Private LimitedActive 3 years 3 monthsMaheshkumar Patel, Nisarg Patel and 2 more are mutual person
Aetos Pharma Private LimitedActive 3 years 3 monthsMaheshkumar Patel and Nisarg Patel are mutual person
Blue Lotus Luxury Homes LlpActive 7 years 4 monthsMaheshkumar Patel and Nisarg Patel are mutual person
- Serifos Pharma Private LimitedActive 2 years 8 months
Nisarg Patel and Siddharth Patel are mutual person
- Sidmex Inovia Private LimitedActive 5 months 13 days
Siddharth Patel and Yashvant Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sini Brook Biotech?
Sini Brook Biotech has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sini Brook Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sini Brook Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
